(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Pixelworks, Meta Platforms, and RiceBran Technologies.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Pixelworks (PXLW) | 2.13 | 20.34% | 2024-02-01 19:49:06 |
| 2 | Meta Platforms (META) | 473.66 | 19.98% | 2024-02-02 15:25:14 |
| 3 | RiceBran Technologies (RIBT) | 0.13 | 17.12% | 2024-02-02 02:23:07 |
| 4 | Edwards Lifesciences (EW) | 86.38 | 9.74% | 2024-02-02 15:55:02 |
| 5 | Sangamo Therapeutics (SGMO) | 0.50 | 9.41% | 2024-02-02 07:47:06 |
| 6 | Fastly (FSLY) | 22.60 | 8.97% | 2024-02-02 15:02:14 |
| 7 | XPO Logistics (XPO) | 94.96 | 8.06% | 2024-02-02 15:01:54 |
| 8 | Shopify (SHOP) | 82.64 | 7.72% | 2024-02-02 15:50:04 |
| 9 | Amazon (AMZN) | 171.29 | 7.54% | 2024-02-02 15:25:11 |
| 10 | SkyWest (SKYW) | 58.05 | 7.32% | 2024-02-02 10:17:07 |
The three biggest losers today are FibroGen, Liberty Broadband, and Liberty Broadband.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | FibroGen (FGEN) | 1.92 | -18.99% | 2024-02-02 15:27:46 |
| 2 | Liberty Broadband (LBRDK) | 67.15 | -17.32% | 2024-02-02 15:29:13 |
| 3 | Liberty Broadband (LBRDA) | 66.76 | -17.16% | 2024-02-02 15:29:11 |
| 4 | Charter Comm (CHTR) | 317.70 | -16.91% | 2024-02-02 15:26:34 |
| 5 | Atlassian (TEAM) | 218.41 | -14.31% | 2024-02-02 15:51:57 |
| 6 | Signature Bank (SBNY) | 1.30 | -13.33% | 2024-02-02 05:15:05 |
| 7 | Aspen Group (ASPU) | 0.16 | -10% | 2024-02-02 13:15:59 |
| 8 | Spero Therapeutics (SPRO) | 1.42 | -9.55% | 2024-02-02 13:12:06 |
| 9 | Selective Insurance Group (SIGI) | 96.80 | -7.69% | 2024-02-02 09:11:06 |
| 10 | SunPower Corporation (SPWR) | 3.42 | -7.57% | 2024-02-02 13:15:09 |
Winners today
1. Pixelworks (PXLW) – 20.34%
Pixelworks, Inc., together with its subsidiaries, develops and markets semiconductor and software solutions for mobile, home entertainment, content, and business and education markets. The company provides video display processor products, including image processor integrated circuits, such as embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing within high-end display systems; video co-processor integrated circuits that work with an image processor to post-process video signals to enhance the performance or feature set of the overall video solution; and transcoder integrated circuits, which comprise embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing for converting bitrates, resolutions, and codecs. As of March 31, 2022, it had an intellectual property portfolio of 334 patents related to the visual display of digital image data. The company sells its through a direct sales force, distributors, and manufacturers' representatives in Japan, China, Taiwan, the United States, Europe, and Korea. Pixelworks, Inc. was incorporated in 1997 and is based in Portland, Oregon.
NASDAQ ended the session with Pixelworks rising 20.34% to $2.13 on Friday, after three successive sessions in a row of gains. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Pixelworks has a trailing twelve months EPS of $-0.44.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.38%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 400% and positive 40% for the next.
Volume
Today’s last reported volume for Pixelworks is 3692740 which is 147.06% above its average volume of 1494640.
Yearly Top and Bottom Value
Pixelworks’s stock is valued at $2.13 at 16:32 EST, way under its 52-week high of $2.44 and way higher than its 52-week low of $1.01.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Pixelworks’s EBITDA is -2.43.
More news about Pixelworks.
2. Meta Platforms (META) – 19.98%
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.
NASDAQ ended the session with Meta Platforms rising 19.98% to $473.66 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
Meta platforms stock news: META blows past market as zuckerberg offers lofty outlookHowever, most equity indices, including the S&P 500 and NASDAQ Composite, blasted higher due to earnings success from Meta Platforms and Amazon (AMZN).
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $11.33.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 41.81. Meaning, the purchaser of the share is investing $41.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.27%.
Moving Average
Meta Platforms’s worth is way above its 50-day moving average of $349.36 and way above its 200-day moving average of $300.87.
Previous days news about Meta Platforms
- Is a surprise coming for meta platforms (meta) this earnings season?. According to Zacks on Wednesday, 31 January, "That is because Meta Platforms is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. "
- Is meta platforms (meta) a solid growth stock? 3 reasons to think "yes". According to Zacks on Thursday, 1 February, "This combination positions Meta Platforms well for outperformance, so growth investors may want to bet on it.", "While the historical EPS growth rate for Meta Platforms is 15.6%, investors should actually focus on the projected growth. "
More news about Meta Platforms.
3. RiceBran Technologies (RIBT) – 17.12%
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.
NASDAQ ended the session with RiceBran Technologies rising 17.12% to $0.13 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, RiceBran Technologies has a trailing twelve months EPS of $-1.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.59%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 26.8%, now sitting on 39.38M for the twelve trailing months.
More news about RiceBran Technologies.
4. Edwards Lifesciences (EW) – 9.74%
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
NYSE ended the session with Edwards Lifesciences jumping 9.74% to $86.38 on Friday while NYSE dropped 0% to $17,115.75.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.34.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 36.91. Meaning, the purchaser of the share is investing $36.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.06%.
Yearly Top and Bottom Value
Edwards Lifesciences’s stock is valued at $86.38 at 16:32 EST, under its 52-week high of $94.87 and way higher than its 52-week low of $60.57.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 5.82B for the twelve trailing months.
Moving Average
Edwards Lifesciences’s value is way higher than its 50-day moving average of $72.19 and way above its 200-day moving average of $78.38.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Edwards Lifesciences’s EBITDA is 90.25.
More news about Edwards Lifesciences.
5. Sangamo Therapeutics (SGMO) – 9.41%
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
NASDAQ ended the session with Sangamo Therapeutics rising 9.41% to $0.50 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.37%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 64.5%, now sitting on 201.42M for the twelve trailing months.
Volume
Today’s last reported volume for Sangamo Therapeutics is 1649560 which is 0.64% above its average volume of 1639070.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sangamo Therapeutics’s EBITDA is 0.01.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 18.8% and a drop 191.7% for the next.
More news about Sangamo Therapeutics.
6. Fastly (FSLY) – 8.97%
Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.
NYSE ended the session with Fastly jumping 8.97% to $22.60 on Friday, following the last session’s upward trend. NYSE fell 0% to $17,115.75, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Fastly has a trailing twelve months EPS of $-1.24.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.16%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Fastly’s stock is considered to be overbought (>=80).
More news about Fastly.
7. XPO Logistics (XPO) – 8.06%
XPO, Inc. provides freight transportation services in the United States, rest of North America, France, the United Kingdom, rest of Europe, and internationally. The company operates in two segments, North American LTL and European Transportation. The North American LTL segment provides customers with less-than-truckload (LTL) services, such as geographic density and day-definite domestic services. This segment also offers cross-border U.S., Mexico, Canada, and the Caribbean, as well as engages in the operation of trailer manufacturing. The European Transportation segment offers dedicated truckload, LTL, truck brokerage, managed transportation, last mile, freight forwarding and multimodal solutions, such as road-rail and road-short sea combinations. It provides its services to customers in various industries, such as industrial and manufacturing, retail and e-commerce, food and beverage, logistics and transportation, and consumer goods. The company was formerly known as XPO Logistics, Inc. and changed its name to XPO, Inc. in December 2022. XPO, Inc. was incorporated in 2000 and is based in Greenwich, Connecticut.
NYSE ended the session with XPO Logistics jumping 8.06% to $94.96 on Friday while NYSE dropped 0% to $17,115.75.
Earnings Per Share
As for profitability, XPO Logistics has a trailing twelve months EPS of $0.82.
PE Ratio
XPO Logistics has a trailing twelve months price to earnings ratio of 115.8. Meaning, the purchaser of the share is investing $115.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, XPO Logistics’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 7.63B for the twelve trailing months.
Sales Growth
XPO Logistics’s sales growth is 4.8% for the present quarter and 4.5% for the next.
Volatility
XPO Logistics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.56%, a negative 0.08%, and a positive 1.48%.
XPO Logistics’s highest amplitude of average volatility was 1.21% (last week), 1.53% (last month), and 1.48% (last quarter).
More news about XPO Logistics.
8. Shopify (SHOP) – 7.72%
Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company's platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. It also sells custom themes and apps, and registration of domain names; and merchant solutions, which include accepting payments, shipping and fulfillment, and securing working capital. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.
NYSE ended the session with Shopify rising 7.72% to $82.64 on Friday, after three successive sessions in a row of losses. NYSE fell 0% to $17,115.75, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Shopify has a trailing twelve months EPS of $-0.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.53%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 342.9% and 2000%, respectively.
More news about Shopify.
9. Amazon (AMZN) – 7.54%
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. It operates through three segments: North America, International, and Amazon Web Services (AWS). The company's products offered through its stores include merchandise and content purchased for resale; and products offered by third-party sellers. It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Rings, Blink, eero, and Echo; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as fulfillment, advertising, and digital content subscriptions. Additionally, the company offers Amazon Prime, a membership program. It serves consumers, sellers, developers, enterprises, content creators, and advertisers. The company was incorporated in 1994 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Amazon jumping 7.54% to $171.29 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around positive trend exchanging session today.
China sales take a bite out of Apple, Amazon and meta set to surge on US openPrices for Amazon services have gone up, we’ve seen that with Amazon Prime and Prime Video, while job losses have also been taking place in these areas of the business., When Amazon reported in Q3, Q4 guidance was set at net sales of $160-167bn, with the company adding it would be hiring 250k full and part-time employees to cover the holiday periods of Thanksgiving and Christmas.
Earnings Per Share
As for profitability, Amazon has a trailing twelve months EPS of $2.9.
PE Ratio
Amazon has a trailing twelve months price to earnings ratio of 59.07. Meaning, the purchaser of the share is investing $59.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.53%.
Previous days news about Amazon
- Amazon (amzn) tops Q4 earnings and revenue estimates. According to Zacks on Thursday, 1 February, "While Amazon has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
More news about Amazon.
10. SkyWest (SKYW) – 7.32%
SkyWest, Inc., through its subsidiaries, operates a regional airline in the United States. The company operates through two segment, SkyWest Airlines and SkyWest Leasing. It also leases regional jet aircraft and spare engines to third parties. As of December 31, 2021, the company's fleet consisted of 629 aircraft; and provided scheduled passenger and air freight services with approximately 2,080 total daily departures to various destinations in the United States, Canada, Mexico, and the Caribbean. In addition, it offers airport customer and ground handling services for other airlines. SkyWest, Inc. was incorporated in 1972 and is headquartered in St. George, Utah.
NASDAQ ended the session with SkyWest jumping 7.32% to $58.05 on Friday while NASDAQ rose 1.74% to $15,628.95.
Earnings Per Share
As for profitability, SkyWest has a trailing twelve months EPS of $-0.57.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.54%.
Previous days news about SkyWest
- Skywest (skyw) Q4 earnings top estimates. According to Zacks on Thursday, 1 February, "While SkyWest has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Skywest (skyw) Q4 earnings: how key metrics compare to wall street estimates. According to Zacks on Thursday, 1 February, "For the quarter ended December 2023, SkyWest (SKYW Quick QuoteSKYW – Free Report) reported revenue of $751.79 million, up 10.4% over the same period last year. ", "Here is how SkyWest performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about SkyWest.
Losers Today
1. FibroGen (FGEN) – -18.99%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen sliding 18.99% to $1.92 on Friday while NASDAQ jumped 1.74% to $15,628.95.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.
More news about FibroGen.
2. Liberty Broadband (LBRDK) – -17.32%
Liberty Broadband Corporation engages in the communications businesses. The company's GCI Holdings segment provides data, wireless, video, voice, and managed services to residential customers, businesses, governmental entities, educational, and medical institutions in Alaska under the GCI brand. Its Charter segment offers subscription-based Internet and video services, and mobile and voice services; and state-of-the-art residential and business services, which includes Spectrum Internet, TV, mobile and voice for small and medium-sized companies; Spectrum Business provides a suite of broadband products and services for businesses and government application; Spectrum Enterprise offers customized fiber-based solutions; Spectrum Reach provides advertising and production for the modern media landscape. In addition, the company provides security suite that offers computer viruses, spyware and threats from malicious actors across the internet; offers internet access, data networking, fiber connectivity to cellular towers and office buildings, video entertainment, and business telephone services; advertising services on cable television networks, streaming services, and advertising platforms; and operates regional sports and news networks. Liberty Broadband Corporation was incorporated in 2014 and is based in Englewood, Colorado.
NASDAQ ended the session with Liberty Broadband dropping 17.32% to $67.15 on Friday while NASDAQ rose 1.74% to $15,628.95.
Earnings Per Share
As for profitability, Liberty Broadband has a trailing twelve months EPS of $4.55.
PE Ratio
Liberty Broadband has a trailing twelve months price to earnings ratio of 14.76. Meaning, the purchaser of the share is investing $14.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.52%.
Volatility
Liberty Broadband’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.94%, a negative 0.23%, and a positive 1.38%.
Liberty Broadband’s highest amplitude of average volatility was 1.22% (last week), 1.41% (last month), and 1.38% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Liberty Broadband’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 8.8% and 197.9%, respectively.
More news about Liberty Broadband.
3. Liberty Broadband (LBRDA) – -17.16%
Liberty Broadband Corporation engages in the communications businesses. The company's GCI Holdings segment provides data, wireless, video, voice, and managed services to residential customers, businesses, governmental entities, educational, and medical institutions in Alaska under the GCI brand. Its Charter segment offers subscription-based Internet and video services, and mobile and voice services; and state-of-the-art residential and business services, which includes Spectrum Internet, TV, mobile and voice for small and medium-sized companies; Spectrum Business provides a suite of broadband products and services for businesses and government application; Spectrum Enterprise offers customized fiber-based solutions; Spectrum Reach provides advertising and production for the modern media landscape. In addition, the company provides security suite that offers computer viruses, spyware and threats from malicious actors across the internet; offers internet access, data networking, fiber connectivity to cellular towers and office buildings, video entertainment, and business telephone services; advertising services on cable television networks, streaming services, and advertising platforms; and operates regional sports and news networks. Liberty Broadband Corporation was incorporated in 2014 and is based in Englewood, Colorado.
NASDAQ ended the session with Liberty Broadband falling 17.16% to $66.76 on Friday, after two sequential sessions in a row of gains. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, Liberty Broadband has a trailing twelve months EPS of $4.55.
PE Ratio
Liberty Broadband has a trailing twelve months price to earnings ratio of 14.67. Meaning, the purchaser of the share is investing $14.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.52%.
More news about Liberty Broadband.
4. Charter Comm (CHTR) – -16.91%
Charter Communications, Inc. operates as a broadband connectivity and cable operator company serving residential and commercial customers in the United States. The company offers subscription-based internet, video, and mobile and voice services; a suite of broadband connectivity services, including fixed internet, WiFi, and mobile; security suite that protects computers from viruses and spyware, and threats from malicious actors; in-home WiFi, which provides customers with high performance wireless routers and managed WiFi services to enhance their fixed wireless internet experience; out-of-home WiFi; and Spectrum WiFi services. The company also offers voice communications services using voice over internet protocol technology; and broadband communications solutions, such as internet access, data networking, fiber connectivity, video entertainment, and business telephone services to cellular towers and office buildings for business and carrier organizations. In addition, it provides mobile services; video programming, static IP and business WiFi, and e-mail and security services; sells local advertising across various platforms for networks, such as TBS, CNN, and ESPN; sells advertising inventory to local sports and news channels; and offers Audience App to create data-driven linear TV campaigns for local advertisers. Further, the company offers communications products and managed service solutions; data connectivity services to mobile and wireline carriers on a wholesale basis; and owns and operates regional sports and news networks. It serves approximately 32 million customers in 41 states. The company was founded in 1993 and is headquartered in Stamford, Connecticut.
NASDAQ ended the session with Charter Comm dropping 16.91% to $317.70 on Friday, following the last session’s upward trend. NASDAQ rose 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Charter Comm has a trailing twelve months EPS of $30.62.
PE Ratio
Charter Comm has a trailing twelve months price to earnings ratio of 10.38. Meaning, the purchaser of the share is investing $10.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.99%.
More news about Charter Comm.
5. Atlassian (TEAM) – -14.31%
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams. The company also offers Jira Service Management, an intuitive and flexible service desk product for creating and managing service experiences for various service team providers, such as IT, legal, and HR teams; and Jira Align, an Atlassian's enterprise agility solution designed to help businesses to adapt and respond dynamic business conditions with a focus on value-creation. In addition, it provides Bitbucket, an enterprise-ready Git solution that enables professional dev teams to manage, collaborate, and deploy quality code; Atlassian Access, an enterprise-wide product for enhanced security and centralized administration that works across every Atlassian cloud product; and Jira Product, a prioritization and road mapping tool. Further, the company's portfolio includes Atlas, a teamwork directory; Bamboo, a continuous delivery pipeline; Crowd, a single sign-on; Crucible, a collaborative code review; Fisheye, a search, track, and visualize code change software; and Compass, a developer experience platform. Additionally, it offers Opsgenie, an on-call and alert management software; Sourcetree, a free git client for windows and mac; Statuspage that communicates real-time status to users; Beacon, an intelligent threat detection software; and Atlassian Access that enhance data security and governance for Atlassian Cloud products. The company was founded in 2002 and is headquartered in Sydney, Australia.
NASDAQ ended the session with Atlassian falling 14.31% to $218.41 on Friday, after two sequential sessions in a row of gains. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Atlassian has a trailing twelve months EPS of $-1.96.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -80.45%.
Yearly Top and Bottom Value
Atlassian’s stock is valued at $218.41 at 16:32 EST, way under its 52-week high of $254.09 and way higher than its 52-week low of $128.02.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 3.71B for the twelve trailing months.
Moving Average
Atlassian’s worth is above its 50-day moving average of $217.62 and way above its 200-day moving average of $187.84.
Previous days news about Atlassian
- Atlassian (team) tops Q2 earnings and revenue estimates. According to Zacks on Thursday, 1 February, "While Atlassian has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Atlassian (team) reports Q2 earnings: what key metrics have to say. According to Zacks on Thursday, 1 February, "Here is how Atlassian performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Atlassian.
6. Signature Bank (SBNY) – -13.33%
Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and industrial loans, real estate loans, and letters of credit. In addition, it offers asset management and investment products; and retirement products, such as individual retirement accounts and administrative services for retirement vehicles. Further, the company provides wealth management services to its high net worth personal clients; and purchases, sells, and assembles small business administration loans and pools. Additionally, it offers individual and group insurance products, including health, life, disability, and long-term care insurance products for business and private clients. As of December 31, 2021, the company operated 37 private client offices located in the metropolitan New York area, Connecticut, California, and North Carolina. Signature Bank was incorporated in 2000 and is headquartered in New York, New York.
NASDAQ ended the session with Signature Bank sliding 13.33% to $1.30 on Friday, after five sequential sessions in a row of losses. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Signature Bank has a trailing twelve months EPS of $20.76.
PE Ratio
Signature Bank has a trailing twelve months price to earnings ratio of 0.06. Meaning, the purchaser of the share is investing $0.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.87%.
Moving Average
Signature Bank’s value is way above its 50-day moving average of $1.03 and way above its 200-day moving average of $0.31.
More news about Signature Bank.
7. Aspen Group (ASPU) – -10%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group sliding 10% to $0.16 on Friday, after five successive sessions in a row of losses. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.95%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 19%, now sitting on 58.83M for the twelve trailing months.
Volume
Today’s last reported volume for Aspen Group is 29271 which is 9.17% above its average volume of 26811.
Sales Growth
Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.
Moving Average
Aspen Group’s worth is below its 50-day moving average of $0.17 and higher than its 200-day moving average of $0.15.
More news about Aspen Group.
8. Spero Therapeutics (SPRO) – -9.55%
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat MDR gram-negative infections for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. Spero Therapeutics, Inc. has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company is headquartered in Cambridge, Massachusetts.
NASDAQ ended the session with Spero Therapeutics dropping 9.55% to $1.42 on Friday while NASDAQ jumped 1.74% to $15,628.95.
Earnings Per Share
As for profitability, Spero Therapeutics has a trailing twelve months EPS of $0.39.
PE Ratio
Spero Therapeutics has a trailing twelve months price to earnings ratio of 3.64. Meaning, the purchaser of the share is investing $3.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.75%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Spero Therapeutics’s EBITDA is 8.79.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1169.8%, now sitting on 77.7M for the twelve trailing months.
More news about Spero Therapeutics.
9. Selective Insurance Group (SIGI) – -7.69%
Selective Insurance Group, Inc., together with its subsidiaries, provides insurance products and services in the United States. It operates through four segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. The company offers property insurance products, which covers the financial consequences of accidental loss of an insured's real property, personal property, and/or earnings due to the property's loss; and casualty insurance products that covers the financial consequences of employee injuries in the course of employment, and bodily injury and/or property damage to a third party, as well as flood insurance products. It also invests in fixed income investments and commercial mortgage loans, as well as equity securities and alternative investment portfolio. The company offers its insurance products and services to businesses, non-profit organizations, local government agencies, and individuals through independent retail agents and wholesale general agents. Selective Insurance Group, Inc. was founded in 1926 and is headquartered in Branchville, New Jersey.
NASDAQ ended the session with Selective Insurance Group dropping 7.69% to $96.80 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, Selective Insurance Group has a trailing twelve months EPS of $5.84.
PE Ratio
Selective Insurance Group has a trailing twelve months price to earnings ratio of 16.58. Meaning, the purchaser of the share is investing $16.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.32%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 4.23B for the twelve trailing months.
Yearly Top and Bottom Value
Selective Insurance Group’s stock is valued at $96.80 at 16:32 EST, way under its 52-week high of $108.18 and above its 52-week low of $88.60.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 25.7% and 71.7%, respectively.
More news about Selective Insurance Group.
10. SunPower Corporation (SPWR) – -7.57%
SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.
NASDAQ ended the session with SunPower Corporation falling 7.57% to $3.42 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $15,628.95, following the last session’s upward trend on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, SunPower Corporation has a trailing twelve months EPS of $-0.56.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.52%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 260% and a negative 100%, respectively.
Moving Average
SunPower Corporation’s value is way below its 50-day moving average of $4.18 and way under its 200-day moving average of $7.43.
More news about SunPower Corporation.
Stay up to date with our winners and losers daily report
